1-3 of 3
Kim Cocks, MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Baseline Characteristics Associated with Quality of Life in CLL Patients Requiring Therapy.

Monica Else, MSc, Alastair G. Smith, MD, Sue M. Richards, DPhil, Kim Cocks, MSc, Shirley Crofts, MSc, Daniel Catovsky, MD
Journal: Blood
Blood (2007) 110 (11): 2062.
https://doi.org/10.1182/blood.V110.11.2062.2062
Published: 2007
Journal Articles

Thalidomide Combinations Improve Response Rates; Results from the MRC IX Study.

Gareth J. Morgan, MD, PhD, Faith E. Davies, MD, Roger G. Owen, MD, Andrew C. Rawstron, PhD, Sue Bell, DPhil, Kim Cocks, MSc, Walter Gregory, Graham Jackson, MD, Mark T. Drayson, PhD, Matthew W. Jenner, MD, James A. Child, MD
Journal: Blood
Blood (2007) 110 (11): 3593.
https://doi.org/10.1182/blood.V110.11.3593.3593
Published: 2007
Journal Articles

NCRI CLL201 Trial: A Randomized Phase II Trial of Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) with or without Rituximab in Previously Treated CLL.

Peter Hillmen, MBChB, PhD, Christopher Pocock, MB, BS, PhD, Dena Cohen, MSc, Kim Cocks, MSc, Hazem A. Sayala, MB, BCh, Andy Rawstron, PhD, Daniel B. Kennedy, MB, ChB, Christopher Fegan, MB, BS, Don W. Milligan, MB, ChB, Claire Dearden, MB, BS, Alexandra Smith, BSc, Emma Lindop, BSc, Andrew R. Pettitt, MB, BChir, PhD
Journal: Blood
Blood (2007) 110 (11): 752.
https://doi.org/10.1182/blood.V110.11.752.752
Published: 2007